Since BRCA1 carriers usually have a higher-grade disease, and more frequently hormone-negative, diagnosing DCIS earlier would be extremely important to try to prevent these carcinomas evolving into an invasive disease. This evidence concerns the gene BRCA1 and ductal breast carcinoma in situ.